VBIV Annual FCF
-$61.75 M
+$16.29 M+20.87%
31 December 2023
Summary:
As of February 5, 2025, VBIV annual free cash flow is -$61.75 million, with the most recent change of +$16.29 million (+20.87%) on December 31, 2023. During the last 3 years, it has fallen by -$13.70 million (-28.51%).VBIV Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Quarterly FCF
-$11.92 M
+$306.00 K+2.50%
31 March 2024
Summary:
As of February 5, 2025, VBIV quarterly free cash flow is -$11.92 million, with the most recent change of +$306.00 thousand (+2.50%) on March 31, 2024. Over the past year, it has increased by +$7.34 million (+38.10%).VBIV Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV TTM FCF
-$51.48 M
+$10.27 M+16.63%
31 March 2024
Summary:
As of February 5, 2025, VBIV TTM free cash flow is -$51.48 million, with the most recent change of +$10.27 million (+16.63%) on March 31, 2024. Over the past year, it has increased by +$29.04 million (+36.07%).VBIV TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.9% | +38.1% | +36.1% |
| 3 y3 years | -28.5% | +41.8% | +34.0% |
| 5 y5 years | -19.8% | +41.8% | +34.0% |
VBIV Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | <-9999.0% | -9076.7% | <-9999.0% |
VBI Vaccines Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$11.92 M(-2.5%) | -$51.48 M(-16.6%) |
| Dec 2023 | -$61.75 M(-20.9%) | -$12.23 M(+51.5%) | -$61.75 M(-11.8%) |
| Sept 2023 | - | -$8.07 M(-58.1%) | -$70.02 M(-13.0%) |
| June 2023 | - | -$19.26 M(-13.2%) | -$80.52 M(+0.9%) |
| Mar 2023 | - | -$22.19 M(+8.3%) | -$79.79 M(+2.2%) |
| Dec 2022 | -$78.04 M(+86.2%) | -$20.50 M(+10.4%) | -$78.04 M(+1.8%) |
| Sept 2022 | - | -$18.57 M(+0.3%) | -$76.67 M(+22.6%) |
| June 2022 | - | -$18.53 M(-9.4%) | -$62.55 M(+13.4%) |
| Mar 2022 | - | -$20.44 M(+6.9%) | -$55.14 M(+31.6%) |
| Dec 2021 | -$41.90 M(-12.8%) | -$19.13 M(+329.3%) | -$41.90 M(+5.3%) |
| Sept 2021 | - | -$4.46 M(-59.9%) | -$39.80 M(-21.4%) |
| June 2021 | - | -$11.12 M(+54.5%) | -$50.65 M(+6.7%) |
| Mar 2021 | - | -$7.20 M(-57.7%) | -$47.47 M(-1.2%) |
| Dec 2020 | -$48.05 M(-8.3%) | -$17.03 M(+11.3%) | -$48.05 M(+20.9%) |
| Sept 2020 | - | -$15.30 M(+92.6%) | -$39.74 M(+2.1%) |
| June 2020 | - | -$7.94 M(+2.1%) | -$38.90 M(-12.1%) |
| Mar 2020 | - | -$7.78 M(-10.7%) | -$44.25 M(-15.5%) |
| Dec 2019 | -$52.38 M(+1.7%) | -$8.72 M(-39.7%) | -$52.38 M(-2.3%) |
| Sept 2019 | - | -$14.46 M(+8.8%) | -$53.59 M(-1.1%) |
| June 2019 | - | -$13.29 M(-16.5%) | -$54.17 M(-6.4%) |
| Mar 2019 | - | -$15.92 M(+60.4%) | -$57.85 M(+12.3%) |
| Dec 2018 | -$51.53 M(+60.9%) | -$9.92 M(-34.0%) | -$51.53 M(+0.6%) |
| Sept 2018 | - | -$15.04 M(-11.4%) | -$51.21 M(+21.8%) |
| June 2018 | - | -$16.97 M(+76.9%) | -$42.03 M(+27.0%) |
| Mar 2018 | - | -$9.59 M(-0.1%) | -$33.10 M(+3.4%) |
| Dec 2017 | -$32.02 M(+67.6%) | -$9.61 M(+63.9%) | -$32.02 M(+4.5%) |
| Sept 2017 | - | -$5.86 M(-27.1%) | -$30.64 M(+7.4%) |
| June 2017 | - | -$8.04 M(-5.5%) | -$28.54 M(+9.3%) |
| Mar 2017 | - | -$8.51 M(+3.5%) | -$26.11 M(+36.7%) |
| Dec 2016 | -$19.10 M(+97.4%) | -$8.22 M(+118.6%) | -$19.10 M(+75.6%) |
| Sept 2016 | - | -$3.76 M(-33.0%) | -$10.88 M(+52.8%) |
| June 2016 | - | -$5.62 M(+274.0%) | -$7.12 M(+245.5%) |
| Mar 2016 | - | -$1.50 M(+169.1%) | -$2.06 M(-17.4%) |
| Dec 2015 | -$9.68 M(+255.0%) | - | - |
| June 2015 | - | -$558.20 K(-42.3%) | -$2.49 M(-8.4%) |
| Mar 2015 | - | -$967.00 K(+234.1%) | -$2.72 M(-14.9%) |
| Mar 2015 | -$2.73 M(-60.4%) | - | - |
| Dec 2014 | - | -$289.40 K(-57.4%) | -$3.20 M(-29.1%) |
| Sept 2014 | - | -$679.80 K(-13.6%) | -$4.51 M(-13.2%) |
| June 2014 | - | -$786.60 K(-45.5%) | -$5.20 M(-24.6%) |
| Mar 2014 | -$6.89 M(-19.4%) | -$1.44 M(-9.8%) | -$6.89 M(-19.7%) |
| Dec 2013 | - | -$1.60 M(+17.3%) | -$8.58 M(+9.8%) |
| Sept 2013 | - | -$1.36 M(-44.9%) | -$7.82 M(-15.1%) |
| June 2013 | - | -$2.48 M(-21.0%) | -$9.20 M(+7.7%) |
| Mar 2013 | -$8.54 M(-40.2%) | -$3.14 M(+275.1%) | -$8.54 M(-3.0%) |
| Dec 2012 | - | -$836.20 K(-69.6%) | -$8.81 M(-22.5%) |
| Sept 2012 | - | -$2.75 M(+51.6%) | -$11.36 M(-0.8%) |
| June 2012 | - | -$1.82 M(-46.6%) | -$11.46 M(-19.9%) |
| Mar 2012 | -$14.30 M | -$3.40 M(+0.5%) | -$14.30 M(-9.9%) |
| Dec 2011 | - | -$3.39 M(+19.0%) | -$15.87 M(+9.2%) |
| Sept 2011 | - | -$2.85 M(-38.8%) | -$14.53 M(+18.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2011 | - | -$4.66 M(-6.4%) | -$12.27 M(+38.3%) |
| Mar 2011 | -$8.87 M(+315.4%) | -$4.98 M(+142.5%) | -$8.87 M(+78.6%) |
| Dec 2010 | - | -$2.05 M(+249.3%) | -$4.97 M(+50.0%) |
| Sept 2010 | - | -$587.50 K(-53.2%) | -$3.31 M(-0.0%) |
| June 2010 | - | -$1.26 M(+17.3%) | -$3.31 M(+55.0%) |
| Mar 2010 | -$2.14 M(+699.8%) | -$1.07 M(+170.3%) | -$2.14 M(+88.0%) |
| Dec 2009 | - | -$396.30 K(-32.6%) | -$1.14 M(+49.9%) |
| Sept 2009 | - | -$588.10 K(+628.7%) | -$758.00 K(+168.0%) |
| June 2009 | - | -$80.70 K(+12.9%) | -$282.80 K(+5.9%) |
| Mar 2009 | -$267.10 K(-66.8%) | -$71.50 K(+304.0%) | -$267.10 K(-12.6%) |
| Dec 2008 | - | -$17.70 K(-84.3%) | -$305.70 K(-48.5%) |
| Sept 2008 | - | -$112.90 K(+73.7%) | -$594.00 K(-18.5%) |
| June 2008 | - | -$65.00 K(-41.0%) | -$728.70 K(-9.4%) |
| Mar 2008 | -$804.00 K(+18.8%) | -$110.10 K(-64.0%) | -$804.10 K(-22.5%) |
| Dec 2007 | - | -$306.00 K(+23.6%) | -$1.04 M(+11.8%) |
| Sept 2007 | - | -$247.60 K(+76.4%) | -$928.30 K(+23.3%) |
| June 2007 | - | -$140.40 K(-59.2%) | -$753.00 K(+11.3%) |
| Mar 2007 | -$676.80 K(+64.0%) | -$344.10 K(+75.4%) | -$676.80 K(+47.2%) |
| Dec 2006 | - | -$196.20 K(+171.4%) | -$459.80 K(+32.7%) |
| Sept 2006 | - | -$72.30 K(+12.6%) | -$346.60 K(-18.3%) |
| June 2006 | - | -$64.20 K(-49.5%) | -$424.20 K(+2.7%) |
| Mar 2006 | -$412.80 K(+122.4%) | -$127.10 K(+53.1%) | -$412.90 K(+169.9%) |
| Dec 2005 | - | -$83.00 K(-44.6%) | -$153.00 K(+1.6%) |
| Sept 2005 | - | -$149.90 K(+183.4%) | -$150.60 K(-27.5%) |
| June 2005 | - | -$52.90 K(-139.8%) | -$207.80 K(+12.0%) |
| Mar 2005 | -$185.60 K(-38.6%) | $132.80 K(-264.8%) | -$185.60 K(-67.9%) |
| Dec 2004 | - | -$80.60 K(-61.1%) | -$577.50 K(0.0%) |
| Sept 2004 | - | -$207.10 K(+574.6%) | -$577.50 K(+44.2%) |
| June 2004 | - | -$30.70 K(-88.2%) | -$400.40 K(+32.5%) |
| Mar 2004 | -$302.10 K(+751.0%) | -$259.10 K(+221.5%) | -$302.20 K(+887.6%) |
| Dec 2003 | - | -$80.60 K(+168.7%) | -$30.60 K(-194.4%) |
| Sept 2003 | - | -$30.00 K(-144.4%) | $32.40 K(-25.9%) |
| June 2003 | - | $67.50 K(+440.0%) | $43.70 K(-222.8%) |
| Mar 2003 | -$35.50 K(-2466.7%) | $12.50 K(-171.0%) | -$35.60 K(-22.6%) |
| Dec 2002 | - | -$17.60 K(-5.9%) | -$46.00 K(+9.5%) |
| Sept 2002 | - | -$18.70 K(+58.5%) | -$42.00 K(+303.8%) |
| June 2002 | - | -$11.80 K(-661.9%) | -$10.40 K(-793.3%) |
| Mar 2002 | $1500.00(-101.0%) | $2100.00(-115.4%) | $1500.00(-68.8%) |
| Dec 2001 | - | -$13.60 K(-205.4%) | $4800.00(-96.4%) |
| Sept 2001 | - | $12.90 K(>+9900.0%) | $133.30 K(+91.0%) |
| June 2001 | - | $100.00(-98.1%) | $69.80 K(-152.6%) |
| Mar 2001 | -$157.60 K(<-9900.0%) | $5400.00(-95.3%) | -$132.80 K(-3.9%) |
| Dec 2000 | - | $114.90 K(-327.1%) | -$138.20 K(-45.4%) |
| Sept 2000 | - | -$50.60 K(-75.0%) | -$253.10 K(+25.0%) |
| June 2000 | - | -$202.50 K(+43.1%) | -$202.50 K(-4.2%) |
| Mar 2000 | $0.00(-100.0%) | - | - |
| Mar 1999 | -$66.30 K(-68.6%) | - | - |
| Mar 1998 | -$211.30 K(-51.4%) | -$141.50 K(-5760.0%) | -$211.40 K(+202.4%) |
| Dec 1997 | - | $2500.00(-103.5%) | -$69.90 K(-3.5%) |
| Sept 1997 | - | -$72.40 K(<-9900.0%) | -$72.40 K(<-9900.0%) |
| June 1997 | - | $0.00 | $0.00 |
| Mar 1997 | -$434.80 K | - | - |
FAQ
- What is VBI Vaccines annual free cash flow?
- What is the all time high annual FCF for VBI Vaccines?
- What is VBI Vaccines annual FCF year-on-year change?
- What is VBI Vaccines quarterly free cash flow?
- What is the all time high quarterly FCF for VBI Vaccines?
- What is VBI Vaccines quarterly FCF year-on-year change?
- What is VBI Vaccines TTM free cash flow?
- What is the all time high TTM FCF for VBI Vaccines?
- What is VBI Vaccines TTM FCF year-on-year change?
What is VBI Vaccines annual free cash flow?
The current annual FCF of VBIV is -$61.75 M
What is the all time high annual FCF for VBI Vaccines?
VBI Vaccines all-time high annual free cash flow is $1500.00
What is VBI Vaccines annual FCF year-on-year change?
Over the past year, VBIV annual free cash flow has changed by +$16.29 M (+20.87%)
What is VBI Vaccines quarterly free cash flow?
The current quarterly FCF of VBIV is -$11.92 M
What is the all time high quarterly FCF for VBI Vaccines?
VBI Vaccines all-time high quarterly free cash flow is $132.80 K
What is VBI Vaccines quarterly FCF year-on-year change?
Over the past year, VBIV quarterly free cash flow has changed by +$7.34 M (+38.10%)
What is VBI Vaccines TTM free cash flow?
The current TTM FCF of VBIV is -$51.48 M
What is the all time high TTM FCF for VBI Vaccines?
VBI Vaccines all-time high TTM free cash flow is $133.30 K
What is VBI Vaccines TTM FCF year-on-year change?
Over the past year, VBIV TTM free cash flow has changed by +$29.04 M (+36.07%)